Trajectories of forced vital capacity in patients with systemic sclerosis-associated interstitial lung disease

Abstract We used data from the SENSCIS and SENSCIS-ON trials to assess decline in forced vital capacity (FVC) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD) who received long-term treatment with nintedanib and the effect of switching patients from placebo to ninte...

Description complète

Détails bibliographiques

Auteurs principaux:	Oliver Distler, Madelon C Vonk, Arata Azuma, Maureen D. Mayes, Dinesh Khanna, Kristin B. Highland, Gerrit Toenges, Margarida Alves, Yannick Allanore
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2025-03-01
Collection:	Arthritis Research & Therapy
Sujets:	Disease progression Pulmonary fibrosis Pulmonary function tests Systemic scleroderma
Accès en ligne:	https://doi.org/10.1186/s13075-025-03524-9
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!